10x Genomics, Inc. TXG Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s pre-tax income?
- 10x Genomics, Inc. (TXG) reported pre-tax income of -$12.85M in Q1 2026.
- How has 10x Genomics, Inc.'s pre-tax income changed year-over-year?
- 10x Genomics, Inc.'s pre-tax income increased by 61.7% year-over-year, from -$33.51M to -$12.85M.
- What is the long-term trend for 10x Genomics, Inc.'s pre-tax income?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s pre-tax income has grown at a -7.2% compound annual growth rate (CAGR), from -$53.72M to -$39.91M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.